Not reported
Active11323970Private limited companyLondon
NOVAMUNE LIMITED
Significant control: Mark William Lowdell (25–50%), Linda Powers (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Novamune Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Novamune Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
NOVAMUNE LIMITED is an active private limited company (company number 11323970) incorporated on 23 April 2018, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 April 2025 and cash of £22, with 2 employees on average.
There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.
02
Ownership and control
- Mr Mark William Lowdell
- owns 25–50% of shares
- Linda Powers
- owns 50–75% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 23 April 20188 yrs ago
- Next accounts due
- 30 January 2027in 97 days
- Confirmation statement due
- 7 May 2027in 194 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£22
−48%vs Apr 2024Not reported
2
No changevs Apr 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | — | £22 | £0 | — | — | — | 2 |
| 30 April 2024 | — | £42 | £3 | — | — | — | 2 |
Cash per employee£11Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Incorporated five or more years agoIncorporated 23 April 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 194 days
- Next accounts duein 97 days
- Accounts period end
- Accounts period end
- Incorporated
08
Similar companies in London
- CANNBIOREX PHARMA LIMITEDLondon · inc. Apr 2018
- ALMRO CLINICAL RESEARCH SOLUTIONS LTDLondon · inc. Apr 2018
- CODETO LTDLondon · inc. Apr 2018
- MBS5 LIMITEDLondon · inc. May 2018
- DIGITAL BIOSCIENCES LIMITEDLondon · inc. Mar 2018
- INNOVATIVE BIORESEARCH LTDLondon · inc. May 2018
All companies incorporated on 23 April 2018 · in Apr 2018.
09
Reminders for NOVAMUNE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.